Mesalazine Oral Suspension in Active Eosinophilic Esophagitis

NCT05488405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Mesalamine Oral Product

Sponsor

Dr. Falk Pharma GmbH